2013 EUROPEAN LEUKEMIANET RESPONSE CRITERIA VALIDATION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH 3 AVAILABLE TKIS OUTSIDE CLINICAL TRIALS

被引：0
|
作者：
Breccia, M. [1 ]
Pregno, P. [2 ]
Annunziata, M. [3 ]
Orlandi, E. [4 ]
Gozzini, A. [5 ]
Iurlo, A. [6 ]
Bocchia, M. [7 ]
Franceschini, L. [8 ]
Montefusco, E. [9 ]
Crugnola, M. [10 ]
La Nasa, G. [11 ]
Scortechini, A. R. [12 ]
Sgherza, N. [13 ]
Sica, S. [14 ]
Alimena, G. [1 ]
Saglio, G. [15 ]
Specchia, G. [16 ]
机构：
[1] Univ Roma La Sapienza, Hematol, Dept Cellular Biotechnol & Hematol, Rome, Italy
[2] Citta Salute & Sci Torino AOU, Hematol, Turin, Italy
[3] Cardarelli Hosp, Hematol, Naples, Italy
[4] Fdn IRCSS Policlin San Matteo, Hematol, Pavia, Italy
[5] Careggi Hosp AOU, Hematol, Florence, Italy
[6] Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Hematol, Milan, Italy
[7] Univ Siena, Hematol, Siena, Italy
[8] Univ Roma Tor Vergata, Rome, Italy
[9] S Andrea Hosp, Hematol, Rome, Italy
[10] Parma AOU, Hematol, Parma, Italy
[11] Univ Cagliari, Hematol, Dept Med Sci, Cagliari, Italy
[12] Osped Riuniti Ancona, Hematol, Ancona, Italy
[13] IRCSS Ist Tumori Giovanni Paolo II, Hematol, Bari, Italy
[14] Univ Cattolica, Hematol, Rome, Italy
[15] Univ Turin, Hematol, Turin, Italy
[16] Policlin Consorziale Bari AOU, Hematol, Bari, Italy
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1827
引用
收藏
页码：738 / 739
页数：2
相关论文
共 50 条
  • [31] Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials
    Suh, Koung Jin
    Lee, Ji Yun
    Shin, Dong-Yeop
    Koh, Youngil
    Bang, Soo-Mee
    Yoon, Sung-Soo
    Park, Seonyang
    Kim, Inho
    Lee, Jeong-Ok
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (02) : 229 - 239
  • [32] Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials
    Koung Jin Suh
    Ji Yun Lee
    Dong-Yeop Shin
    Youngil Koh
    Soo-Mee Bang
    Sung-Soo Yoon
    Seonyang Park
    Inho Kim
    Jeong-Ok Lee
    International Journal of Hematology, 2017, 106 : 229 - 239
  • [33] PREDICTORS OF DEEP MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH IMATINIB MESYLATE: AN ANALYSIS BY THE GIMEMA CML WP
    Castagnetti, F.
    Gugliotta, G.
    Breccia, M.
    Specchia, G.
    Binotto, G.
    Abruzzese, E.
    Iurlo, A.
    Vigneri, P.
    Cavazzini, F.
    Intermesoli, T.
    Ferrero, D.
    Martino, B.
    Leoni, P.
    Bocchia, M.
    Rege-Cambrin, G.
    Gherlinzoni, F.
    Bochicchio, M. T.
    Soverini, S.
    Alimena, G.
    Pane, F.
    Saglio, G.
    Cavo, M.
    Martinelli, G.
    Baccarani, M.
    Rosti, G.
    HAEMATOLOGICA, 2015, 100 : 324 - 324
  • [34] Therapy in Patients with Chronic Myeloid Leukemia Outside of Clinical Trials: Results of the German CML-Registry (CML-VI)
    Kohlbrenner, Katharina
    Galuschek, Norbert
    Fabarius, Alice
    Reiser, Marcel
    Fenchel, Klaus
    Esseling, Eva
    Goehler, Thomas
    Geer, Thomas
    Depenbusch, Reinhard
    Azeh, Ivo Talah
    Engel, Erik
    Hansen, Richard
    Lindemann, Hans-Walter
    Anhuf, Juergen
    Jehner, Paul
    Abu-Samra, Maisun
    Ritter, Markus
    Gattermann, Norbert
    Pelz, Henning
    Fuxius, Stefan
    Oswald, Burkhard
    Baerlocher, Gabriela M.
    Brummendorf, Tim H. H.
    Heim, Dominik
    le Coutre, Philipp
    Burchert, Andreas
    Niederwieser, Dietger
    Tesch, Hans
    Hofmann, Wolf-Karsten
    Hochhaus, Andreas
    Hehlmann, Ruediger
    Saussele, Susanne
    BLOOD, 2022, 140
  • [35] Chronic Myeloid Leukemia: How Can Minimal Cytogenetic Response After 3 Months of Treatment Be Classified According to the New European LeukemiaNet Recommendations? Reply
    Baccarani, Michele
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18) : E311 - E311
  • [36] The BCR-ABL1 Transcript Type Does Not Influence the Response and the Outcome of Chronic Myeloid Leukemia Patients Treated Frontline with Nilotinib
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Palandri, Francesca
    Breccia, Massimo
    Stagno, Fabio
    Levato, Luciano
    Fava, Carmen
    Luciano, Luigiana
    Intermesoli, Tamara
    Cedrone, Michele
    Carella, Angelo Michele
    Cavazzini, Francesco
    Turri, Diamante
    Avanzini, Paolo
    Pierri, Ivana
    Lunghi, Monia
    Venturi, Claudia
    Soverini, Simona
    Testoni, Nicoletta
    Alimena, Giuliana
    Saglio, Giuseppe
    Martinelli, Giovanni
    Pane, Fabrizio
    Baccarani, Michele
    Rosti, Gianantonio
    BLOOD, 2012, 120 (21)
  • [37] THE EUTOS LONG-TERM SURVIVAL SCORING SYSTEM IS PREDICTIVE FOR RESPONSE AND OUTCOME IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH NILOTINIB
    Castagnetti, F.
    Gugliotta, G.
    Breccia, M.
    Stagno, F.
    D'Adda, M.
    Levato, L.
    Angelucci, E.
    Martino, B.
    Tiribelli, M.
    Fava, C.
    Binotto, G.
    Avanzini, P.
    Bocchia, M.
    Bergamaschi, M.
    Russo-Rossi, A.
    Cavazzini, F.
    Abruzzese, E.
    Soverini, S.
    Foa, R.
    Cavo, M.
    Martinelli, G.
    Saglio, G.
    Pane, F.
    Baccarani, M.
    Rosti, G.
    HAEMATOLOGICA, 2017, 102 : 86 - +
  • [38] European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor
    Marin, David
    Milojkovic, Dragana
    Olavarria, Eduardo
    Khorashad, Jamshid S.
    de lavallade, Hugues
    Reid, Alistair G.
    Foroni, Letizia
    Rezvani, Katayoun
    Bua, Marco
    Dazzi, Francesco
    Pavlu, Jiri
    Klammer, Matthias
    Kaeda, Jaspal S.
    Goldman, John M.
    Apperley, Jane F.
    BLOOD, 2008, 112 (12) : 4437 - 4444
  • [39] Chronic Myeloid Leukemia (CML) Patients with "Suboptimal" Response to Imatinib (IM) According to European LeukemiaNet Criteria Have a Poorer Outcome with Respect to "Optimal" Responders: A GIMEMA CML WORKING PARTY Analysis.
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Palandri, Francesca
    Breccia, Massimo
    Amabile, Marilina
    Iacobucci, Ilaria
    Testoni, Nicoletta
    Marzocchi, Giulia
    Luatti, Simona
    Specchia, Giorgina
    Intermesoli, Tamara
    Abruzzese, Elisabetta
    Capucci, Adele
    Levato, Luciano
    Radaelli, Franca
    Martino, Bruno
    Pregno, Patrizia
    Montefusco, Enrico
    Trentin, Livio
    Alimena, Giuliana
    Martinelli, Giovanni
    Pane, Fabrizio
    Saglio, Giuseppe
    Baccarani, Michele
    Rosti, Gianantonio
    BLOOD, 2009, 114 (22) : 864 - 864
  • [40] SYSTEMATIC REVIEW OF CLINICAL TRIALS AND PROSPECTIVE COHORTS: FOLLOW UP METHODS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH DASATINIB
    Grazziotin, L. R.
    Stoll, P.
    Wust, D.
    Hegele, V.
    Ehrembrick, G.
    Caregnato, J.
    Lindenmeyer, L.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (12): : 4710 - 4721
12345